Switzerland

Holding a smiling baby

World’s first malaria treatment for newborn babies gets approval

By / / Good News For Humankind

Switzerland’s drug regulator has cleared the way for a new medicine to become available in parts of Africa where the life-threatening disease is endemic. In a late-stage clinical trial, pharmaceutical giant Novartis showed the drug was safe and effective for babies. The lack of specialized treatment – and the fact that babies are not vaccinated until they are around five months old – has left the youngest infants relatively unprotected against malaria, a mosquito-borne disease that kills about 597,000 people per year.

digitally colorized scanning electron microscopic (SEM) image, depicts a blue-colored, human white blood cell, (WBC) known specifically as a neutrophil, interacting with two pink-colored, rod shaped, multidrug-resistant (MDR), Klebsiella pneumoniae bacteria

Global child deaths from pneumonia have been cut in half since 2009

By / / Good news links

Pneumonia kills 2,000 children under five worldwide every day, making it the world’s biggest infectious cause of death in children. The introduction of pneumococcal conjugate vaccines (PCVs) has significantly lowered the burden of death and disease from pneumonia, but millions of children remain unvaccinated. Since the public-private global health partnership Gavi supported the first roll-out of the PCV vaccine in 2009, 438 million children of all ages have been vaccinated in 64 countries, averting an estimated total of 1.2 million deaths by the end of 2023.